- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Vaccitech gets $168m series B injection
The spinout’s technology was fundamental to Oxford’s covid vaccine, prompting OSI and Future Planet Capital to back a $168m round.
Mar 17, 2021RentoMojo homes in on $21m for series C
The GMO, Mitsui Sumitomo and Samsung-backed furniture rental platform developer has added $1.4m to its latest round to take its total funding to $35m.
Mar 16, 2021Bhansali breezes in to Scan Group
Binoy Bhansali was previously at Sandbox Industries, which manages $1.2bn across four funds for health insurer Blue Cross Blue Shield.
Mar 16, 2021Variantyx picks IBM for $20m series C
IBM Ventures participated in a $20m round for the neurological disease diagnostics technology spinout of Tel Aviv University.
Mar 16, 2021Rising Stars Q&A – Kurt Sheline, Echo Health Ventures
Q&A with Kurt Sheline, principal, Echo Health Ventures
Mar 16, 2021Daily deal net: March 16, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mar 16, 2021VLP Therapeutics raises $16m
Miyako Capital has contributed to a series A round for the cancer vaccine developer, which expanded to Japan last year.
Mar 16, 2021Monte Rosa scales $95m series C
The money will fund the progress of the University of London-linked precision medicine developer's lead drug candidate into the clinic.
Mar 16, 2021Fondeadora fattens series A to $28m
Google subsidiary Gradient Ventures returned for a $14m second tranche of the round, having led the August 2020 first close.
Mar 16, 2021VLP Therapeutics raises $16m
Konishiyasu and Sojitz contributed to a series A round for the cancer vaccine developer, which expanded to their home of Japan last year.
Mar 16, 2021Corporates help ElevateBio get $525m lift
SoftBank Vision Fund 2, Itochu and an unnamed insurer took part in a series C round that hiked the gene and cell therapy developer's total funding to $845m.
Mar 16, 2021Variantyx picks IBM for $20m series C
IBM Ventures participated in a $20m round for the neurological disease diagnostics technology developer, a spinout from Tel Aviv University.
Mar 16, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
